These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 9723527
1. Use of pharmacologic immunosuppression to augment the specific unresponsiveness (tolerance) to skin allografts induced by donor-specific bone marrow in antilymphocyte serum-treated mice: the unique effect of sirolimus. Hale D, Gottschalk R, Maki T, Monaco AP. Transplant Proc; 1998 Aug; 30(5):2432-4. PubMed ID: 9723527 [Abstract] [Full Text] [Related]
2. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA, Gottschalk R, Maki T, Monaco AP. Transplantation; 1998 Feb 27; 65(4):473-9. PubMed ID: 9500619 [Abstract] [Full Text] [Related]
3. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA, Gottschalk R, Fukuzaki T, Wood ML, Maki T, Monaco AP. Transplantation; 1997 Feb 15; 63(3):359-64. PubMed ID: 9039923 [Abstract] [Full Text] [Related]
9. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells. De Fazio SR, Plowey JM, Hartner WC, Gozzo JJ. Transpl Immunol; 1996 Jun 15; 4(2):105-12. PubMed ID: 8843586 [Abstract] [Full Text] [Related]
10. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice. De Fazio SR, Plowey J, Hartner WC, Gozzo JJ. Transplant Proc; 1994 Dec 15; 26(6):3102-3. PubMed ID: 7998084 [No Abstract] [Full Text] [Related]
14. Studies in rodents on the use of polyclonal antilymphocyte serum and donor-specific bone marrow to induce specific unresponsiveness to skin allografts. Monaco AP. Transplant Proc; 1991 Aug 15; 23(4):2061-7. PubMed ID: 1871820 [No Abstract] [Full Text] [Related]
15. Synergistic effect of immunosuppressive drug and intrathymic inoculation of donor cells in skin graft survival. Dono K, Wood ML, Ozato H, Monaco AP. Transplant Proc; 1994 Oct 15; 26(5):3061. PubMed ID: 7940963 [No Abstract] [Full Text] [Related]
16. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients. Gozzo JJ, Kowolenko M. Transplant Proc; 1987 Feb 15; 19(1 Pt 1):470-1. PubMed ID: 3274809 [No Abstract] [Full Text] [Related]
17. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Hale DA, Gottschalk R, Umemura A, Maki T, Monaco AP. Transplantation; 2000 Apr 15; 69(7):1242-51. PubMed ID: 10798737 [Abstract] [Full Text] [Related]
18. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. Hara Y, Matsuura T, Imanishi M, Tahara H, Kurita T. Transplant Proc; 1994 Dec 15; 26(6):3226-8. PubMed ID: 7527955 [No Abstract] [Full Text] [Related]
19. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation. Matsuura T, Imanishi M, Hara Y, Tahara H, Kanda H, Kurita T. Transplant Proc; 1994 Aug 15; 26(4):1962-3. PubMed ID: 7520616 [No Abstract] [Full Text] [Related]
20. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients. Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW. Transplant Proc; 1995 Feb 15; 27(1):423-6. PubMed ID: 7879047 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]